Biguanides

Results: 159



#Item
1119984502XXXXXXX  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET.

9984502XXXXXXX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-18 16:26:28
112Starlix® (nateglinide) tablets Rx only Prescribing Information  DESCRIPTION

Starlix® (nateglinide) tablets Rx only Prescribing Information DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-08-26 14:56:45
113GLUCOVANCE®  (Glyburide and Metformin HCl) Tablets 1.25 mg/250 mg 2.5 mg/500 mg

GLUCOVANCE® (Glyburide and Metformin HCl) Tablets 1.25 mg/250 mg 2.5 mg/500 mg

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-10-18 16:38:57
114HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA™ safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA™ safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

Add to Reading List

Source URL: www.invokanahcp.com

Language: English - Date: 2014-05-23 17:07:54
115Opinion of the Scientific Committee on Consumer Safety on o-aminophenol (A14)

Opinion of the Scientific Committee on Consumer Safety on o-aminophenol (A14)

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-07-03 11:41:04
116HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PrandiMet safely and effectively. See full prescribing information for PrandiMet. ·················

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PrandiMet safely and effectively. See full prescribing information for PrandiMet. ·················

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-04-26 16:06:05
117HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JANUMET XR safely and effectively. See full prescribing information for JANUMET XR. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-10-22 15:48:00
118ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets ACTOPLUS MET® XR  (pioglitazone hydrochloride and metformin hydrochloride extended-release) tablets

ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets ACTOPLUS MET® XR (pioglitazone hydrochloride and metformin hydrochloride extended-release) tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-08-04 14:45:15
119NDA[removed]S-007 Page 3 Bristol-Myers Squibb Company Rx only

NDA[removed]S-007 Page 3 Bristol-Myers Squibb Company Rx only

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-02-11 16:13:38
120C:�a�iew� review�betis�covance Ped N21178�mary for Ped.doc

C:aiew reviewbetiscovance Ped N21178mary for Ped.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-02-11 16:13:38